The U.S. equity market breathed a sigh of relief on Dec. 16 after the U.S. Federal Reserve disclosed its plans for reduced monthly bond-buying and increased interest rates for 2022. The central bank's aggressive stance on managing the stickier-than-expected inflation can prove to be a major headwind for several growth stocks. Especially those relying excessively on cheap capital. However, fundamentally strong companies with several growth catalysts and robust financial performance could easily withstand those headwinds.
Companies like Marvell Technology (NASDAQ: MRVL) and Halozyme Therapeutics (NASDAQ: HALO) can prove to be attractive picks for retail investors, even if they have only $1,000 to invest. Here's why.
Image Source: Getty Images.
For further details see:
2 Game-Changing Stocks to Invest $1,000 in Right Now